I’ll be fairly brief today with my Friday musings for you today, because I’m off to the Grant’s Interest Rate Observer Conference on Tuesday next week and I expect I’ll be writing a few extra notes for the Irregulars based on what I see in those presentations. I’m particularly interested in hearing the thoughts of […]
Trading service that recommends long-dated out-of-the-money put options to profit from companies with weak financials.
The folks at Money Map Press are following in the footsteps of a few other advisories by trying to not just pitch publicly traded stocks, but to pitch the idea that they can get you access to a specific private investment deal that you can’t find elsewhere. That’s probably true in some cases — there […]
This percolated up to the “most asked about” teaser pitch over the weekend, and it’s easy to see why — everyone loves royalties (or as the newsletters like to call it, “getting money for free without doing any hard work”), and Sid Riggs is saying that “you can get super rich in a matter of […]
Today we’ve got a two-fer — two different big publishers are teasing different “liquid biopsy” stocks, and I’m no expert on the technology or the prospects for this diagnostic “trend” that we’ve been hearing more about… so I’ll just sift the clues, identify the companies, and let you chatter about their merits amongst yourselves. The […]
I haven’t rushed in to cover this teaser pitch over the past few days, partly because I’ve already written about so many of the overhyped Money Map Press ads recently and partly because Gumshoe readers have already discussed it a little bit (and identified the stock) … … but a lot of you have been […]
Michael Robinson has been pitching “Living Metal” again recently, as an add-on to some of his ads for Nova-X Report over the last few weeks, so I thought I’d take another look at it for you. This is no longer the centerpiece of any promo campaigns that I can see, it was mentioned late in […]
Golly, most people who might subscribe to investment newsletters are baby boomers. And most of that generation is just a few years past their midlife crisis… so you can be pretty sure that a “silent epidemic” will get them to read your ad, yes? Apparently so, if the questions rolling in to Gumshoe HQ over […]
I haven’t looked at a teaser pitch from Private Briefing for a while, that’s the “pay as you go” monthly newsletter from Bill Patalon at Money Map Press — in the interim, the it looks like the price has just about tripled to $19.99 a month (that’s $239.88 a year for those who are math […]
“I’m going to make a $1.95 million bet. “You see, over the next few minutes, I’m going to show you a simple pattern I believe will allow you to achieve two incredible feats… “You could capture a series of 164.68% windfalls, and… “You will, with 100% certainty, only buy stocks that are going up. “At […]
This article first ran on October 8, 2014. The ad is running heavily again as of early March, and remains more or less unchanged… the article below is unchanged as well. The stock teased has returned about 14% since the article first ran, roughly twice the gain of the S&P 500. Our headline today is […]
I haven’t looked at the Capital Wave Forecast stuff from Shah Gilani in quite a while, so the latest teaser pitch from him and the Money Map folks caught my eye — particularly because he’s touting big moves in specific large-cap “blue chip” type stocks, which is pretty rare in newsletterdom (it’s a lot easier […]
Heads up: I made a mistake on this one when it first went up on the site. We strive for at least a 99% accuracy rate in identifying teaser targets, and this is apparently my mistake for 2014. Thanks to several readers for alerting me to the fact that I moved too quickly in posting […]
Fast-paced technical trading service.
Premium-priced trading service for small cap stocks, frequent “rocket stock” alerts.
Michael Robinson has been a big booster of tech ideas for his Nova-X Report, and lately he’s trying to sell his newsletter by using a special report that he says will reveal “The Wearable Tech Investment Opportunity of a Lifetime.” So naturally, Gumshoe readers want to know who it is. The spiel starts off with […]
I know a great many of the Irregulars have been interested in FDA dates recently, partly thanks to the community of biotech enthusiasts who have coalesced around the musings of our own Dr. KSS, so I thought I’d spin out a quick answer to you for a teaser pitch that’s been sent out quite breathlessly […]
Monthly newsletter that aims to pick stocks to benefit from big technology trends. Michael Robinson also edits the more expensive Radical Technology Profits for the same publisher.
Newsletter/trading service that aims to track important trading catalyst dates for biotech stocks, including FDA approvals and submissions and clinical trial data releases. Formerly called BioScience Millionaire.